Rana, Ushnish http://orcid.org/0000-0001-6783-6193
Xu, Ke
Narayanan, Amal http://orcid.org/0000-0001-8159-6878
Walls, Mackenzie T. http://orcid.org/0000-0002-1857-987X
Panagiotopoulos, Athanassios Z.
Avalos, José L. http://orcid.org/0000-0002-7209-4208
Brangwynne, Clifford P. http://orcid.org/0000-0002-1350-9960
Funding for this research was provided by:
Howard Hughes Medical Institute
United States Department of Defense | United States Air Force | AFMC | Air Force Office of Scientific Research (FA9550-20-1-0241, FA9550-20-1-0241, FA9550-20-1-0241, FA9550-20-1-0241)
National Science Foundation (DMR-1420541, DGE-1656466, DMR-1420541)
U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research
Article History
Received: 10 March 2023
Accepted: 19 January 2024
First Online: 21 February 2024
Competing interests
: C.P.B. is a founder and consultant for Nereid Therapeutics. All other authors declare no competing interests.